Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

corcym Perceval Plus LANCELOT

FDA-approved surgical aortic valve implanted for first time in US

The next-generation valve from Corcym features a sutureless frame as well as laser-cut leaflets and thread holes.

MiniMed Flex Medtronic

FDA clears MiniMed’s screenless, smartphone-controlled insulin pump

Just weeks after separating from Medtronic and going public, MiniMed secured FDA clearance for its next-generation insulin pump technology. 

heart patient stretching at home

Morning exercise may have added benefits for the heart

With exercise, does timing really matter? According to one new study, working out early in the day was linked to a lower risk of heart disease and healthier blood pressure levels than working out at any other point in the day.

FDA issues recall of imaging systems

FDA issues emergency alert on surgical stapler reloads after 1 death, 4 injuries

The problem is limited to surgical stapler reloads used by the da Vinci robot, specifically those manufactured by Intuitive Surgical. The FDA said it’s currently investigating why the reloads are leaving incomplete line formations. For now, they need to be pulled from all patient care settings. 

Thumbnail

Ultra-processed foods significantly increase a person’s risk of heart attack or stroke

Study participants who ate high amounts of ultra-processed foods were 66.8% more likely to experience a heart attack, stroke or cardiac arrest than those who did not.

acute kidney injury after TAVR

Acute kidney injury after TAVR: Key risk factors every cardiologist should know

Multiple studies have linked acute kidney injury after TAVR to a heightened risk of short- and long-term mortality. 

A single injection of saNppa lipid nanoparticles enables self-amplification and high-yield pro-ANP production for more than 28 days. Circulating pro-ANP is selectively cleaved by the cardiac protease corin into active ANP, activating NPR1/cGMP signaling in the heart. Image courtesy of Science, Kaiyue Zhang et al. https://www.science.org/doi/10.1126/science.adu9394

Single injection could help heal heart attack damage

Amplifying the body’s natural release of a specific hormone may reduce stress on the heart and limit long‑term damage after myocardial infarctions.  

FDA approves JenaValve TAVR system for aortic regurgitation

The Trilogy Transcatheter Heart Valve System is the first TAVR device approved by the FDA to treat severe aortic regurgitation. Until now, interventional cardiologists have had to settle for the off-label use of TAVR valves built for treating aortic stenosis.